ORCID as entered in ROS

Select Publications
2010, 'P75 neurotrophin receptor regulates basal and fluoxetine-stimulated hippocampal neurogenesis', Experimental Brain Research, 200, pp. 161 - 167, http://dx.doi.org/10.1007/s00221-009-1947-6
,2010, 'Cytotoxic effects of antipsychotic drugs implicate cholesterol homeostasis as a novel chemotherapeutic target.', International Journal of Cancer, 126, pp. 28 - 40
,2008, 'The p75 neurotrophin receptor regulates hippocampal neurogenesis and related behaviours', European Journal of Neuroscience, 28, pp. 883 - 892, http://dx.doi.org/10.1111/j.1460-9568.2008.06390.x
,2008, 'Cancer incidence in patients with schizophrenia and their first-degree relatives - A meta-analysis', Acta Psychiatrica Scandinavica, 117, pp. 323 - 336, http://dx.doi.org/10.1111/j.1600-0447.2008.01163.x
,2006, 'Dose determination of haloperidol, risperidone and olanzapine using an in vivo dopamine D2-receptor occupancy method in the rat', European Journal of Pharmacology, 540, pp. 87 - 90, http://dx.doi.org/10.1016/j.ejphar.2006.04.048
,2006, 'Apoptosis and schizophrenia: A pilot study based on dermal fibroblast cell lines', Schizophrenia Research, 84, pp. 20 - 28
,2001, 'High Level resistance to Glucocorticoids, assosiated with a dysfunctional glucocorticoid receptor, in childhood acute lymphoblastic leukemia cells selected for methotrexate resistance', Leukemia, 15, pp. 929 - 935
,2000, 'Apoptosis and schizophrenia: Is the tumour suppressor gene,p53, a candidate susceptibility gene?', Schizophrenia Research, pp. 405 - 415
,